Lacutoclax Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

Guangzhou Lupeng Pharmaceutical Company LTD.1

Indications

Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma1
Cancer1

Other1 trial

A Study of Lacutoclax (LP-108) in Patients With Relapsed/Refractory CLL/SLL

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.